Pelthos Therapeutics PTHS
NYSE PTHS
$21.50 +0.29 (+1.34%)
As of: Sep 30, 2026 · 2:27 PM EDT

Pelthos Therapeutics (PTHS) Finished Goods (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) reported Finished Goods of $8.99 million for Q2 2026, up 3.4% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Finished Goods (2025 - 2026) Analysis & Trends

At the end of FY2025, Pelthos Therapeutics posted Finished Goods of $6.58 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Pelthos Therapeutics 78.87 Mn -9.52 Mn 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.99 Mn
Mar 31, 2026 8.70 Mn
Dec 31, 2025 6.58 Mn
API Access

Pelthos Therapeutics Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=PTHS&period=max&api_key=YOUR_API_KEY